Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2008-07-08
2008-07-08
Campell, Bruce (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S185100, C424S204100, C424S194100
Reexamination Certificate
active
07396531
ABSTRACT:
The present invention relates to the use of selected polypeptides from African Swine virus for the prevention and therapy of African Swine infections as well as other infections, including immune deficiencies in mammals and humans.
REFERENCES:
patent: 5880095 (1999-03-01), Park et al.
Neilan et al., Neutralizing antibodies to African swine fever virus proteins p30, p54 and p72 are not sufficient for antibody-mediated protection, 2004, Virology, vol. 319, pp. 337-342.
Simon-Mateo et al., Polyprotien processing in African swine fever virus: a novel gene express strategy for a DNA virus, 1993, The EMBO Journal, vol. 12, No. 7, pp. 2977-2987.
Genbank Accession #CAA80455, African Swine Fever Virus Polyprotein 220, Accessioned Apr. 29, 1995.
Niedzwiecki Aleksandra
Rath Matthias
Blumel Benjamin P.
Campell Bruce
Chen, Esq. Alexander
Kamarei, Esq. Ali
LandOfFree
Preventive and therapeutic use of polypeptides from African... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preventive and therapeutic use of polypeptides from African..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preventive and therapeutic use of polypeptides from African... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2772455